small molecule

STATROL

NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Loss of exclusivity—loss of exclusivity

CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand name	STATROL
Active ingredient	NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength	EQ 3.5MG BASE/ML;16,250 UNITS/ML
Dosage form	SOLUTION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	November 1984
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.